Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
2014 · American Heart Journal · 409 citations
https://doi.org/10.1016/j.ahj.2014.07.028